Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW-3102 in Hypercholesterolemia
NCT02368613Phase 2Unknown
- Sponsor
- Daewon Pharm
- Primary completion
- Oct 2017
01
Overview
A Phase 2 trial of DW-3102 in hypercholesterolemia, sponsored by Daewon Pharm. Status: unknown.
02
Drugs
DW-3102
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02368613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368613.